Literature DB >> 28890504

An Alarmingly High Proportion of HIV-1 Isolates Carrying Mutations Corresponding to Resistance to Antiretroviral Drugs among HIV-Positive High-Risk Groups in Central Vietnam: a Substudy of the National Sentinel Survey.

Hung Thai Do1,2,3, Dong Thanh Nguyen1, Lan Anh Thi Nguyen4, Duong Huy Do4, Huy Xuan Le1, Xuan Mai Thi Trinh1, Hong Vy Nu Ton1, Ikumi Sawada2, Noriko Kitamura2, Minh Nhat Le2, Keisuke Yoshihara2,3, Thu Huong Thi Phan5, Chien Trong Bui1, Koya Ariyoshi2,3, Lay Myint Yoshida2,3.   

Abstract

We studied the prevalence of HIV drug resistance among high-risk groups such as injecting drug users (IDUs), female sex workers (FSWs), and men having sex with men (MSM) in central Vietnam. We used HIV-positive blood samples from 2012-2013 sentinel surveillance surveys. Study subjects were screened for HIV infection by standardized screening assays, and the HIV-positive samples were further tested for HIV viral load and drug-resistance mutations (DRMs) by in-house assays. DRMs were identified using the Stanford University online sequence analysis tool. Their risk behaviors were also investigated. During the study period, 6,016 (high-risk) subjects were screened, and 97 tested positive for HIV infection (IDUs: n = 63, 3.0%; FSWs: n = 24, 0.9%; and MSM: n = 10, 1.0%). Ninety-two of the 97 samples (45 from 2012 and 47 from 2013) were available for further testing. HIV RNA was detected in 56 (60.9%) of the 92 samples, and drug resistance genotyping was successfully performed on 40 (71.4%) samples. All these isolates were subtype CRF01_AE, except for 1 (2.5%) IDU whose HIV belongs to subtype B. Thirteen individuals (32.5%) were carrying HIV with at least 1 DRM: 9 IDUs, 1 FSW, and 3 MSM. Thus, HIV seroprevalence among high-risk individuals in central Vietnam is low, but a high proportion of drug resistant HIV-1 isolates is observed in the high-risk group.

Entities:  

Keywords:  antiretroviral drug resistance; high-risk group; human immunodeficiency virus (HIV); risk behavior

Mesh:

Substances:

Year:  2017        PMID: 28890504     DOI: 10.7883/yoken.JJID.2016.512

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN: 1344-6304            Impact factor:   1.362


  3 in total

1.  Cross-Neutralizing CRF01_AE-Infected Plasma from Malaysia Targets CD4-Binding Site of Human Immunodeficiency Virus Type-1 Envelope Glycoprotein.

Authors:  Qi Ron Ng; Kok Keng Tee; James M Binley; Tommy Tong
Journal:  AIDS Res Hum Retroviruses       Date:  2021-06-17       Impact factor: 1.723

2.  HIV drug resistance in persons who inject drugs enrolled in an HIV prevention trial in Indonesia, Ukraine, and Vietnam: HPTN 074.

Authors:  Philip J Palumbo; Yinfeng Zhang; Jessica M Fogel; Xu Guo; William Clarke; Autumn Breaud; Paul Richardson; Estelle Piwowar-Manning; Stephen Hart; Erica L Hamilton; Ngo T K Hoa; Mariya Liulchuk; Latifah Anandari; Tran Viet Ha; Kostyantyn Dumchev; Zubairi Djoerban; Irving Hoffman; Brett Hanscom; William C Miller; Susan H Eshleman
Journal:  PLoS One       Date:  2019-10-10       Impact factor: 3.240

3.  Increased HIV-1 pretreatment drug resistance with consistent clade homogeneity among ART-naive HIV-1 infected individuals in Ethiopia.

Authors:  Mulugeta Kiros; Dawit Hailu Alemayehu; Eleni Geberekidan; Adane Mihret; Melanie Maier; Woldaregay Erku Abegaz; Andargachew Mulu
Journal:  Retrovirology       Date:  2020-09-29       Impact factor: 4.602

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.